What amount sold does X1 Biotech Inc. report in Form D filings?

The latest linked filings report $235K sold across 3 identified offering(s). 1 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was X1 Biotech Inc.'s most recent SEC filing?

X1 Biotech Inc.'s most recent Form D filing was on 2026-06-15.

How many investors does X1 Biotech Inc. have?

The most recent Form D filing lists 2 investor(s).

X1 Biotech Inc.

CIK: 0002068848·Other Technology·NEEDHAM, MA·Corporation

Reported Sold

$235,000

Total Filings

Identified Offerings

Last Filed

Jun 15, 2026

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately. 1 unlinked amendment excluded.

Offering filing timeline

Jun 15, 2026Form D — New notice

Reported sold: $40,000 · Target: $2,000,000

Rule 506(b)·2 investors

Dec 11, 2025Form D/A — Amendment

Reported sold: $95,000 · Target: $300,000

No verified predecessor available.

Rule 506(b)·5 investors

May 21, 2025Form D — New notice

Reported sold: $100,000 · Target: $2,000,000

Rule 506(b)·1 investor

May 21, 2025Form D — New notice

Reported sold: $95,000 · Target: $200,000

Rule 506(b)·5 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

25%

Latest reported sold across 3 identified offerings

$235,000

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

1 unlinked amendment excluded.

Key People

Lawrence Kaufman

Executive Officer

Appears on 3 filings

Michael Aceti

Executive Officer

Appears on 3 filings

Leo Kim

Director

Appears on 3 filings

Joseph Arboleda-Valasquez

Director

Appears on 3 filings

Dean Eliott

Director

Appears on 3 filings

Filing History

Date	Type	Offering target	Reported sold	Investors
Jun 15, 2026	New	$2,000,000	$40,000	2
Dec 11, 2025	Amendment	$300,000	$95,000	5
May 21, 2025	New	$2,000,000	$100,000	1
May 21, 2025	New	$200,000	$95,000	5

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Cala Systems, Inc.

Other Technology

Offering target: $3,000,000

Filed Oct 27, 2026